Skip to Content

Revasc

Active Substance: desirudin
Common Name: desirudin
ATC Code: B01AE01
Marketing Authorisation Holder: Canyon Pharmaceuticals Ltd.
Active Substance: desirudin
Status: Withdrawn
Authorisation Date: 1997-07-09
Therapeutic Area: Venous Thrombosis
Pharmacotherapeutic Group: Antithrombotic agents

Therapeutic Indication

Prevention of deep venous thrombosis in patients undergoing elective hip or knee replacement surgery.

The marketing authorisation for Revasc has been withdrawn at the request of the marketing-authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide